Author:
Jin Xiao-Hai China Institute of Atomic Energy Radioisotope Department P.O. Box 275 (58) 102413 Beijing (P.R. China)

Search for other papers by Jin Xiao-Hai in
Current site
Google Scholar
PubMed
Close
Restricted access

Abstract  

Shortly after the radioactive radium was discovered, it made people to try using radioaction of Ra in medical therapy of human's diseases(1). But in the past 60 years, the most interests were concentrated in clinical diagnostic techniques of nuclides. Up to date, nuclear and non-nuclear diagnostic techniques of the tumor are quite advanced, the therapeutic application of90Y,226Ra,198Au and32P nuclides have lasted for long time, several decades later, the studies of tumor interventional radiotherapeutic agents are being interested again and made a very great progresses with the development of nuclear instruments. In our institute, we are developing some very important radiotherapeutic agents in vivo for the treatment of bone metastases, hepatic cancer, brain tumor, rheumatic arthritis radioactive synovectomy, pheochromacytoma, neuroblastoma and so on.

  • Collapse
  • Expand

To see the editorial board, please visit the website of Springer Nature.

Manuscript Submission: HERE

For subscription options, please visit the website of Springer Nature.

Journal of Radionalytical and Nuclear Chemistry
Language English
Size A4
Year of
Foundation
1968
Volumes
per Year
1
Issues
per Year
12
Founder Akadémiai Kiadó
Founder's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Publisher Akadémiai Kiadó
Springer Nature Switzerland AG
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
CH-6330 Cham, Switzerland Gewerbestrasse 11.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 0236-5731 (Print)
ISSN 1588-2780 (Online)